Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 795 entries
Sorted by: Best Match Show Resources per page
Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.

Oncotarget

Borst GR, Kumareswaran R, Yücel H, Telli S, Do T, McKee T, Zafarana G, Jonkers J, Verheij M, O'Connor MJ, Rottenberg S, Bristow RG.
PMID: 29152107
Oncotarget. 2017 Sep 15;8(50):87638-87646. doi: 10.18632/oncotarget.20936. eCollection 2017 Oct 20.

Clinical trials are studying the benefits of combining the PARP-1 inhibitor olaparib with chemotherapy and radiotherapy treatment in a variety of cancer increasing the therapeutic ratio for olaparib may come from its ability to modify the tumour microenvironment by...

Cite
Borst GR, Kumareswaran R, Yücel H, et al. Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget. 2017;8(50):87638-87646doi: 10.18632/oncotarget.20936.
Borst, G. R., Kumareswaran, R., Yücel, H., Telli, S., Do, T., McKee, T., Zafarana, G., Jonkers, J., Verheij, M., O'Connor, M. J., Rottenberg, S., & Bristow, R. G. (2017). Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget, 8(50), 87638-87646. https://doi.org/10.18632/oncotarget.20936
Borst, Gerben R, et al. "Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model." Oncotarget vol. 8,50 (2017): 87638-87646. doi: https://doi.org/10.18632/oncotarget.20936
Borst GR, Kumareswaran R, Yücel H, Telli S, Do T, McKee T, Zafarana G, Jonkers J, Verheij M, O'Connor MJ, Rottenberg S, Bristow RG. Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget. 2017 Sep 15;8(50):87638-87646. doi: 10.18632/oncotarget.20936. eCollection 2017 Oct 20. PMID: 29152107; PMCID: PMC5675659.
Copy Download .nbib Format: NLM
Managing the potential and pitfalls during clinical translation of emerging stem cell therapies.

Clinical and translational medicine

Main H, Munsie M, O'Connor MD.
PMID: 24949190
Clin Transl Med. 2014 May 09;3:10. doi: 10.1186/2001-1326-3-10. eCollection 2014.

We are moving into a new era of stem cell research where many possibilities for treatment of degenerative, chronic and/or fatal diseases and injuries are becoming primed for clinical trial. These reports have led millions of people worldwide to...

Cite
Main H, Munsie M, O'Connor MD. Managing the potential and pitfalls during clinical translation of emerging stem cell therapies. Clin Transl Med. 2014;3:10doi: 10.1186/2001-1326-3-10.
Main, H., Munsie, M., & O'Connor, M. D. (2014). Managing the potential and pitfalls during clinical translation of emerging stem cell therapies. Clinical and translational medicine, 310. https://doi.org/10.1186/2001-1326-3-10
Main, Heather, et al. "Managing the potential and pitfalls during clinical translation of emerging stem cell therapies." Clinical and translational medicine vol. 3 (2014): 10. doi: https://doi.org/10.1186/2001-1326-3-10
Main H, Munsie M, O'Connor MD. Managing the potential and pitfalls during clinical translation of emerging stem cell therapies. Clin Transl Med. 2014 May 09;3:10. doi: 10.1186/2001-1326-3-10. eCollection 2014. PMID: 24949190; PMCID: PMC4049443.
Copy Download .nbib Format: NLM
Extranodal rosai-dorfman disease of the bone treated with surgery and radiotherapy.

Rare tumors

Paryani NN, Daugherty LC, O'Connor MI, Jiang L.
PMID: 25568748
Rare Tumors. 2014 Dec 11;6(4):5531. doi: 10.4081/rt.2014.5531. eCollection 2014 Oct 27.

Rosai-Dorfman disease (RDD) is a rare, benign histiocyte disorder originally described by Rosai and Dorfman in 1969 as sinus histiocytosis with massive lymphadenopathy. It most typically presents as massive, painless cervical lymphadenopathy, and it is most often found in...

Cite
Paryani NN, Daugherty LC, O'Connor MI, et al. Extranodal rosai-dorfman disease of the bone treated with surgery and radiotherapy. Rare Tumors. 2014;6(4):5531doi: 10.4081/rt.2014.5531.
Paryani, N. N., Daugherty, L. C., O'Connor, M. I., & Jiang, L. (2014). Extranodal rosai-dorfman disease of the bone treated with surgery and radiotherapy. Rare tumors, 6(4), 5531. https://doi.org/10.4081/rt.2014.5531
Paryani, Nitesh N, et al. "Extranodal rosai-dorfman disease of the bone treated with surgery and radiotherapy." Rare tumors vol. 6,4 (2014): 5531. doi: https://doi.org/10.4081/rt.2014.5531
Paryani NN, Daugherty LC, O'Connor MI, Jiang L. Extranodal rosai-dorfman disease of the bone treated with surgery and radiotherapy. Rare Tumors. 2014 Dec 11;6(4):5531. doi: 10.4081/rt.2014.5531. eCollection 2014 Oct 27. PMID: 25568748; PMCID: PMC4274442.
Copy Download .nbib Format: NLM
Bayesian Analysis of Blood Transfusion in Dracula.

Irish medical journal

O'Connor M, Dunbar N.
PMID: 27685695
Ir Med J. 2016 Feb 19;109(2):362.

No abstract available.

Cite
O'Connor M, Dunbar N. Bayesian Analysis of Blood Transfusion in Dracula. Ir Med J. 2016;109(2):362
O'Connor, M., & Dunbar, N. (2016). Bayesian Analysis of Blood Transfusion in Dracula. Irish medical journal, 109(2), 362.
O'Connor, M, and Dunbar, N. "Bayesian Analysis of Blood Transfusion in Dracula." Irish medical journal vol. 109,2 (2016): 362.
O'Connor M, Dunbar N. Bayesian Analysis of Blood Transfusion in Dracula. Ir Med J. 2016 Feb 19;109(2):362. PMID: 27685695.
Copy Download .nbib Format: NLM
Predictive Factors for the Development of Type 2 Endoleak Following Endovascular Aneurysm Repair.

Seminars in interventional radiology

O'Connor PJ, Lookstein RA.
PMID: 26327746
Semin Intervent Radiol. 2015 Sep;32(3):272-7. doi: 10.1055/s-0035-1558466.

Type 2 endoleak (T2EL) is the most common complication following endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms. The management of T2ELs is controversial due to the relatively low incidence of negative outcomes when secondary intervention is avoided. Some...

Cite
O'Connor PJ, Lookstein RA. Predictive Factors for the Development of Type 2 Endoleak Following Endovascular Aneurysm Repair. Semin Intervent Radiol. 2015;32(3):272-7doi: 10.1055/s-0035-1558466.
O'Connor, P. J., & Lookstein, R. A. (2015). Predictive Factors for the Development of Type 2 Endoleak Following Endovascular Aneurysm Repair. Seminars in interventional radiology, 32(3), 272-7. https://doi.org/10.1055/s-0035-1558466
O'Connor, Paul J, and Lookstein, Robert A. "Predictive Factors for the Development of Type 2 Endoleak Following Endovascular Aneurysm Repair." Seminars in interventional radiology vol. 32,3 (2015): 272-7. doi: https://doi.org/10.1055/s-0035-1558466
O'Connor PJ, Lookstein RA. Predictive Factors for the Development of Type 2 Endoleak Following Endovascular Aneurysm Repair. Semin Intervent Radiol. 2015 Sep;32(3):272-7. doi: 10.1055/s-0035-1558466. PMID: 26327746; PMCID: PMC4540615.
Copy Download .nbib Format: NLM
Pelvic Insufficiency Fractures.

Geriatric orthopaedic surgery & rehabilitation

O'Connor TJ, Cole PA.
PMID: 26246940
Geriatr Orthop Surg Rehabil. 2014 Dec;5(4):178-90. doi: 10.1177/2151458514548895.

Pelvic insufficiency fractures may occur in the absence of trauma or as a result of low-energy trauma in osteoporotic bone. With a growing geriatric population, the incidence of pelvic insufficiency fracture has increased over the last 3 decades and...

Cite
O'Connor TJ, Cole PA. Pelvic Insufficiency Fractures. Geriatr Orthop Surg Rehabil. 2014;5(4):178-90doi: 10.1177/2151458514548895.
O'Connor, T. J., & Cole, P. A. (2014). Pelvic Insufficiency Fractures. Geriatric orthopaedic surgery & rehabilitation, 5(4), 178-90. https://doi.org/10.1177/2151458514548895
O'Connor, Timothy J, and Cole, Peter A. "Pelvic Insufficiency Fractures." Geriatric orthopaedic surgery & rehabilitation vol. 5,4 (2014): 178-90. doi: https://doi.org/10.1177/2151458514548895
O'Connor TJ, Cole PA. Pelvic Insufficiency Fractures. Geriatr Orthop Surg Rehabil. 2014 Dec;5(4):178-90. doi: 10.1177/2151458514548895. PMID: 26246940; PMCID: PMC4252160.
Copy Download .nbib Format: NLM
Development of measures assessing attitudes toward contraband tobacco among a web-based sample of smokers.

Tobacco induced diseases

Adkison SE, O'Connor RJ, Chaiton M, Schwartz R.
PMID: 25914612
Tob Induc Dis. 2015 Mar 27;13(1):7. doi: 10.1186/s12971-015-0032-0. eCollection 2015.

BACKGROUND: As regulation of tobacco products tightens, there are concerns that illicit markets may develop to supply restricted products. However, there are few validated measures to assess attitudes or purchase intentions toward contraband tobacco (CT). As such, it is...

Cite
Adkison SE, O'Connor RJ, Chaiton M, et al. Development of measures assessing attitudes toward contraband tobacco among a web-based sample of smokers. Tob Induc Dis. 2015;13(1):7doi: 10.1186/s12971-015-0032-0.
Adkison, S. E., O'Connor, R. J., Chaiton, M., & Schwartz, R. (2015). Development of measures assessing attitudes toward contraband tobacco among a web-based sample of smokers. Tobacco induced diseases, 13(1), 7. https://doi.org/10.1186/s12971-015-0032-0
Adkison, Sarah E, et al. "Development of measures assessing attitudes toward contraband tobacco among a web-based sample of smokers." Tobacco induced diseases vol. 13,1 (2015): 7. doi: https://doi.org/10.1186/s12971-015-0032-0
Adkison SE, O'Connor RJ, Chaiton M, Schwartz R. Development of measures assessing attitudes toward contraband tobacco among a web-based sample of smokers. Tob Induc Dis. 2015 Mar 27;13(1):7. doi: 10.1186/s12971-015-0032-0. eCollection 2015. PMID: 25914612; PMCID: PMC4409708.
Copy Download .nbib Format: NLM
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents.

Neuroendocrinology

Pavel M, Valle JW, Eriksson B, Rinke A, Caplin M, Chen J, Costa F, Falkerby J, Fazio N, Gorbounova V, de Herder W, Kulke M, Lombard-Bohas C, O'Connor J, Sorbye H, Garcia-Carbonero R.
PMID: 28351033
Neuroendocrinology. 2017;105(3):266-280. doi: 10.1159/000471880. Epub 2017 Mar 29.

No abstract available.

Cite
Pavel M, Valle JW, Eriksson B, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology. 2017;105(3):266-280doi: 10.1159/000471880.
Pavel, M., Valle, J. W., Eriksson, B., Rinke, A., Caplin, M., Chen, J., Costa, F., Falkerby, J., Fazio, N., Gorbounova, V., de Herder, W., Kulke, M., Lombard-Bohas, C., O'Connor, J., Sorbye, H., Garcia-Carbonero, R. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology, 105(3), 266-280. https://doi.org/10.1159/000471880
Pavel, Marianne, et al. "ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents." Neuroendocrinology vol. 105,3 (2017): 266-280. doi: https://doi.org/10.1159/000471880
Pavel M, Valle JW, Eriksson B, Rinke A, Caplin M, Chen J, Costa F, Falkerby J, Fazio N, Gorbounova V, de Herder W, Kulke M, Lombard-Bohas C, O'Connor J, Sorbye H, Garcia-Carbonero R. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology. 2017;105(3):266-280. doi: 10.1159/000471880. Epub 2017 Mar 29. PMID: 28351033.
Copy Download .nbib Format: NLM
Measuring mental health literacy--a review of scale-based measures.

Journal of mental health (Abingdon, England)

O'Connor M, Casey L, Clough B.
PMID: 24785120
J Ment Health. 2014 Aug;23(4):197-204. doi: 10.3109/09638237.2014.910646. Epub 2014 Apr 30.

BACKGROUND: Mental Health Literacy (MHL) has become an important concept in the literature; however, quantitative research on MHL methodology has been limited.AIMS: This review identified peer-reviewed papers investigating MHL, assessed psychometric attributes of scale-based measures of MHL, and the...

Cite
O'Connor M, Casey L, Clough B. Measuring mental health literacy--a review of scale-based measures. J Ment Health. 2014;23(4):197-204doi: 10.3109/09638237.2014.910646.
O'Connor, M., Casey, L., & Clough, B. (2014). Measuring mental health literacy--a review of scale-based measures. Journal of mental health (Abingdon, England), 23(4), 197-204. https://doi.org/10.3109/09638237.2014.910646
O'Connor, Matt, et al. "Measuring mental health literacy--a review of scale-based measures." Journal of mental health (Abingdon, England) vol. 23,4 (2014): 197-204. doi: https://doi.org/10.3109/09638237.2014.910646
O'Connor M, Casey L, Clough B. Measuring mental health literacy--a review of scale-based measures. J Ment Health. 2014 Aug;23(4):197-204. doi: 10.3109/09638237.2014.910646. Epub 2014 Apr 30. PMID: 24785120.
Copy Download .nbib Format: NLM
Synthesis and Characterization of Novel Oxo-Bridged Dinuclear and Hydroxo-Bridged Trinuclear Chromium(III) Assemblies.

Inorganic chemistry

Harton A, Terrell K, Huffman JC, MacDonald C, Beatty A, Li S, O'Connor CJ, Vincent JB.
PMID: 11670168
Inorg Chem. 1997 Oct 08;36(21):4875-4882. doi: 10.1021/ic961247t.

The structural and spectroscopic properties of a novel dinuclear chromium-oxo and a trinuclear chromium-hydroxo complex are reported. The dinuclear assembly, [Cr(2)(&mgr;-O)(2)(&mgr;-O(2)CMe)(bpy)(2)(H(2)O)(2)]ClO(4).bpy.[bpyH]ClO(4) (1), crystallizes in the monoclinic space group Cc with a = 16.8259(8) Å, b = 21.9622(11) Å, c...

Cite
Harton A, Terrell K, Huffman JC, et al. Synthesis and Characterization of Novel Oxo-Bridged Dinuclear and Hydroxo-Bridged Trinuclear Chromium(III) Assemblies. Inorg Chem. 1997;36(21):4875-4882doi: 10.1021/ic961247t.
Harton, A., Terrell, K., Huffman, J. C., MacDonald, C., Beatty, A., Li, S., O'Connor, C. J., & Vincent, J. B. (1997). Synthesis and Characterization of Novel Oxo-Bridged Dinuclear and Hydroxo-Bridged Trinuclear Chromium(III) Assemblies. Inorganic chemistry, 36(21), 4875-4882. https://doi.org/10.1021/ic961247t
Harton, Anthony, et al. "Synthesis and Characterization of Novel Oxo-Bridged Dinuclear and Hydroxo-Bridged Trinuclear Chromium(III) Assemblies." Inorganic chemistry vol. 36,21 (1997): 4875-4882. doi: https://doi.org/10.1021/ic961247t
Harton A, Terrell K, Huffman JC, MacDonald C, Beatty A, Li S, O'Connor CJ, Vincent JB. Synthesis and Characterization of Novel Oxo-Bridged Dinuclear and Hydroxo-Bridged Trinuclear Chromium(III) Assemblies. Inorg Chem. 1997 Oct 08;36(21):4875-4882. doi: 10.1021/ic961247t. PMID: 11670168.
Copy Download .nbib Format: NLM
A Multistep Topotactic Route to the New Mixed-Valence Titanate, Na(2)(-)(x)()(+)(y)()Ca(x)()(/2)La(2)Ti(3)O(10). Electron Localization Effects in a Triple-Layered Perovskite.

Inorganic chemistry

Lalena JN, Cushing BL, Falster AU, Simmons WB, Seip CT, Carpenter EE, O'Connor CJ, Wiley JB.
PMID: 11670590
Inorg Chem. 1998 Sep 07;37(18):4484-4485. doi: 10.1021/ic980611g.

No abstract available.

Cite
Lalena JN, Cushing BL, Falster AU, et al. A Multistep Topotactic Route to the New Mixed-Valence Titanate, Na(2)(-)(x)()(+)(y)()Ca(x)()(/2)La(2)Ti(3)O(10). Electron Localization Effects in a Triple-Layered Perovskite. Inorg Chem. 1998;37(18):4484-4485doi: 10.1021/ic980611g.
Lalena, J. N., Cushing, B. L., Falster, A. U., Simmons, W. B., Seip, C. T., Carpenter, E. E., O'Connor, C. J., & Wiley, J. B. (1998). A Multistep Topotactic Route to the New Mixed-Valence Titanate, Na(2)(-)(x)()(+)(y)()Ca(x)()(/2)La(2)Ti(3)O(10). Electron Localization Effects in a Triple-Layered Perovskite. Inorganic chemistry, 37(18), 4484-4485. https://doi.org/10.1021/ic980611g
Lalena, John N., et al. "A Multistep Topotactic Route to the New Mixed-Valence Titanate, Na(2)(-)(x)()(+)(y)()Ca(x)()(/2)La(2)Ti(3)O(10). Electron Localization Effects in a Triple-Layered Perovskite." Inorganic chemistry vol. 37,18 (1998): 4484-4485. doi: https://doi.org/10.1021/ic980611g
Lalena JN, Cushing BL, Falster AU, Simmons WB, Seip CT, Carpenter EE, O'Connor CJ, Wiley JB. A Multistep Topotactic Route to the New Mixed-Valence Titanate, Na(2)(-)(x)()(+)(y)()Ca(x)()(/2)La(2)Ti(3)O(10). Electron Localization Effects in a Triple-Layered Perovskite. Inorg Chem. 1998 Sep 07;37(18):4484-4485. doi: 10.1021/ic980611g. PMID: 11670590.
Copy Download .nbib Format: NLM
An experimental and computational study of 1,2-hydrogen migrations in 2-hydroxycyclopentylidene and its conjugate base.

The Journal of organic chemistry

Morgan KM, O'Connor MJ, Humphrey JL, Buschman KE.
PMID: 11262102
J Org Chem. 2001 Mar 09;66(5):1600-6. doi: 10.1021/jo001038x.

Thermal decomposition of alpha-hydroxydiazirine 2 gives primarily cyclopentanone and some allylic alcohol, in similar amounts as the known cyclohexyl analogue 1. Calculations (B3LYP/6-31+G) also show cyclopentanone to be the major product of this carbene rearrangement. Diazirine 2 and the...

Cite
Morgan KM, O'Connor MJ, Humphrey JL, et al. An experimental and computational study of 1,2-hydrogen migrations in 2-hydroxycyclopentylidene and its conjugate base. J Org Chem. 2001;66(5):1600-6doi: 10.1021/jo001038x.
Morgan, K. M., O'Connor, M. J., Humphrey, J. L., & Buschman, K. E. (2001). An experimental and computational study of 1,2-hydrogen migrations in 2-hydroxycyclopentylidene and its conjugate base. The Journal of organic chemistry, 66(5), 1600-6. https://doi.org/10.1021/jo001038x
Morgan, K M, et al. "An experimental and computational study of 1,2-hydrogen migrations in 2-hydroxycyclopentylidene and its conjugate base." The Journal of organic chemistry vol. 66,5 (2001): 1600-6. doi: https://doi.org/10.1021/jo001038x
Morgan KM, O'Connor MJ, Humphrey JL, Buschman KE. An experimental and computational study of 1,2-hydrogen migrations in 2-hydroxycyclopentylidene and its conjugate base. J Org Chem. 2001 Mar 09;66(5):1600-6. doi: 10.1021/jo001038x. PMID: 11262102.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 795 entries